Skip to main content
. 2023 Mar 13;25:e41867. doi: 10.2196/41867

Table 1.

Participant descriptions.

Participant ID Sex Race or ethnicity Disease or condition
Participant 1 Female African American Diabetes
Participant 2 Female White Celiac disease
Participant 3 Female White Epilepsy
Participant 4 Female African American Lupus
Participant 5 Male White Prostate cancer
Participant 6 Female White Rare disease
Participant 7 Male White Irritable bowel syndrome
Participant 8 Female White Fibromyalgia
Participant 9 Male White COPDa
Participant 10 Male Hispanic HIV and anal cancer
Participant 11 Female White Multiple sclerosis
Participant 12 Female White EDSb, MCASc, and POTSd
Participant 13 Male White FOPe
Participant 14 Female White Perimenopause, menopause, and postmenopause
Participant 15 Male Hispanic Asthma
Participant 16 Female White Chronic migraine
Participant 17 Female White Chronic migraine
Participant 18 Female Hispanic Psoriatic arthritis
Participant 19 Female Hispanic Parkinson disease
Participant 20 Female White Cystic fibrosis
Participant 21 Male African American Diabetes
Participant 22 Female Asian American Pulmonary arterial hypertension and congestive heart failure
Participant 23 Female African American Multiple myeloma
Participant 24 Female White Rare disease
Participant 25 Female White Lupus
Participant 26 Male White Friedreich ataxia

aCOPD: chronic obstructive pulmonary disease.

bEDS: Ehlers-Danlos syndrome.

cMCAS: mast cell activation syndrome.

dPOTS: postural orthostatic tachycardia syndrome.

eFOP: Fibrodysplasia ossificans progressiva.